BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
FXYD4
,
cell-cell adhesion
,
Breast Cancer
,
Retina
,
Nosology
,
Vitamin E
,
rs4950928
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
Cr(VI
Summary
General Info
Curated Studies
Most Correlated Studies
Effect of PTP inhibition on changes in gene expression after Cr(VI) exposure
Hepatoma Hepa-1c1c7 cells response to benzo[a]pyrene and low-dosage chromium exposure
Hepa1c1c7 mouse hepatomas treated with 25uM potassium chromate(VI) for 90min and untreated controls
Duodenum, jejunum, and palate tissues of B6C3F1 mice treated with sodium dichromate dihydrate
Dermal fibroblast gene expression in response to toxicity induced by hexavalent chromium
Explore Curated Studies Results
Literature
Most Relevant Literature
Reduction of Chromium(VI) mediated by zero-valent magnesium under neutral pH conditions.
Sustainable enhancement of Cr(VI) bioreduction by the isolated Cr(VI)-resistant bacteria.
New perspectives in biomonitoring of metallic elements: the example of hexavalent chromium].
The adsorbent preparation of FeOOH@PU for effective chromium (VI) removal.
Influence of montmorillonite incorporation on ferrihydrite transformation and Cr(VI) behaviors durin…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Sigma CR150 Versus Sigma CR Knee RCT
A Study to Evaluate the Pharmacokinetics of VI-0521 Subjects With Renal Impairment
Thrombin Generation and Platelet Activation in CRS/HIPEC
A VI-0521 Study to Evaluate the Long-term Safety and Efficacy in Type 2 Diabetic Adults
Open-Label Study to Evaluate the Long-Term Safety and Efficacy of VI-0521 in Type 2 Diabetic Adults
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ